Inhibitory effects of activin on the growth and morpholgenesis of primary and transformed mammary epithelial cells.
Activin is a member of the transforming growth factor beta superfamily, which is known to have activities involved in regulating differentiation and development. By using reverse transcription-PCR analysis on immunoaffinity-purified human breast cells, we have found that activin beta a and activin type II receptor are expressed by myoepithelial cells, whereas no expression was detected in other breast cell types. In examining 15 breast cell lines, we have found only four (HBL-100, MCF10-A, PMC-42, and BT 20) to be positive for activin beta a mRNA, whereas all expressed the activin type II receptor. Furthermore, we have found activin A to be a potent growth inhibitor of MCF- 7 cells (at 2 ng/ml), where it causes an arrest in G(1). Activin A does not appear to have an effect on the cell cycle of primary myoepithelial or luminal cells. However, we demonstrate that activin is an inhibitor of tubule formation by human mammary organoids in vitro. These are the first observations of activin and activin receptor in the normal human breast and in human breast cell lines and suggest a role for activin in mammary cell growth and morphogenesis.
Liu
Q Y
QY
Deparment of Medical Oncology, Charing Cross and Westminster Medical School, London, UK.
Niranjan
B
B
Gomes
P
P
Gomm
J J
JJ
Davies
D
D
Coombes
R C
RC
Buluwela
L
L
D028341:Activins; D001483:Base Sequence; D001940:Breast / Q000166:cytology* / Q000378:metabolism; D001943:Breast Neoplasms / Q000378:metabolism / Q000473:pathology*; D002455:Cell Division / Q000187:drug effects; D005260:Female; D006801:Humans; D007265:Inhibins / Q000096:biosynthesis / Q000494:pharmacology*; D008969:Molecular Sequence Data; D009024:Morphogenesis / Q000187:drug effects; D009924:Organ Culture Techniques; D014407:Tumor Cells, Cultured
D028341:Activins; D007265:Inhibins